ATTD 2025 Poster - ABCD Worldwide Audit of Testosterone Deficiency

Testosterone replacement therapy improves glycaemic control and symptoms in men with type 2 diabetes - the ABCD Worldwide Audit

Authors:

T. Hugh Jones, Karim Haider, Ahmed Haider, Umesh Dashora, Robert E, J. Ryder

Discipline

Diabetes Endocrinology
Resource taxonomy
Audit Event resources Posters
Clinical taxonomy
Type 2 diabetes mellitus
Listing status
Current

ABCD Corporate Pharma Sponsors

Gold

  • AstraZeneca UK
  • Eli Lilly and Company

Silver

  • A Menarini Farmaceutica Internazionale SRL

Bronze

  • Sanofi

ABCD Corporate Pump & Device Sponsors

Gold

  • Abbott
  • Dexcom
  • Ypsomed Ltd

Silver

  • A. Menarini Diagnostics
  • Advanced Therapeutics (UK) Ltd
  • Air Liquide Healthcare Ltd
  • Insulet International

Bronze

  • Medtrum Ltd
  • Roche Diabetes Care

Contact

Address for correspondence: 
ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602
Email: info@abcd.care

Follow Us

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is Fifteen Rosehill, Montgomery Way, Rosehill Estate, Carlisle CA1 2RW Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361, whose registered address is Fifteen Rosehill, Montgomery Way, Rosehill Estate, Carlisle CA1 2RW. ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd